Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1N acetyl cysteine[1] Cysteine[2] L-Cysteine ,
Cysteine hydrochloride 💬
--[2] 6, 19 💬
2N Acetyl L Cysteine[1] Cysteine[2] L-Cysteine ,
Cysteine hydrochloride 💬
--[1] 60 💬
3N Acetyl L Leucine[1] Leucine[1] Leucine 💬 --[1] 19 💬
4N acetylcysteine[1] Acetylcysteine[1] Acetylcysteine 💬 --[1] 13 💬
5N''-[(E)-[(2E)-3-[1-(2-nitrophenyl)-1H-pyrrol-2-yl]prop-2-en-1-ylidene]amino]guanidinium acetate[1] Acetate---[1] 46 💬
6N(4,5Bis methanesulfonyl2methylbenzoyl) guanidine hydrochloride monohydrate[1] Guanidine[1] Guanidine hydrochloride 💬 --[1] 113 💬
7N,N,N',N'-tetramethyl-10H-phenothiazine-3,7-diaminium bis(methanesulfonate)[1] Phenothiazine[1] Phenothiazine 💬 --[1] 127 💬
8N,N,N?,N?-tetramethyl-10H-phenothiazine-3,7-diaminium bis(methanesulfonate)[1] Phenothiazine[1] Phenothiazine 💬 --[1] 127 💬
9N,N,N’,N’-tetramethyl-10H-phenothiazine-3,7-diaminium bis(methanesulfonate)[1] Phenothiazine[1] Phenothiazine 💬 --[1] 127 💬
10N-(4,5-Bis methanesulfonyl-2-methyl-benzoyl)guanidine hydrochloride monohydrate[1] Guanidine[1] Guanidine hydrochloride 💬 --[1] 113 💬
11N-(5-hydroxy-2,4- bis(trimethylsilyl)phenyl)-4-oxo- 1,4-dihydroquinoline-3-carboxamide----[1] 299 💬
12N-(5-hydroxy-2,4-bis(trimethylsilyl)phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide----[1] 299 💬
13N-(5-{4-[(3,3-dimethyl-1-azetidinyl)carbonyl]phenyl}[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide----[1] 49 💬
14N-(trans-3-(5-((R)-1-hydroxyethyl)-1,3,4-oxadiazol-2-yl)cyclobutyl)-3-phenylisoxazole-5-carboxamide----[1] 299 💬
15N-0923----[1] 6 💬
16N-3 LC-PUFA----[1] 46 💬
17N-3 Polyunsaturated Fatty Acids----[1] 96 💬
18N-3 PUFAs----[1] 57 💬
19N-[1-((5-cyanopyridin-2-yl)methyl)-1H-pyrazol-3-yl]-2-[4-(1-(trifluoromethyl)cyclopropyl)phenyl]acetamide[1] Acetamide---[1] 154 💬
20N-acetyl Cysteine[1] Cysteine[2] L-Cysteine ,
Cysteine hydrochloride 💬
--[6] 13, 34, 85, 88, 296, 310 💬
21N-Acetyl Cysteine (NAC)[1] Cysteine[2] L-Cysteine ,
Cysteine hydrochloride 💬
--[1] 90 💬
22N-acetyl-cysteine[1] Cysteine[2] L-Cysteine ,
Cysteine hydrochloride 💬
--[1] 84 💬
23N-Acetyl-L Leucine[1] Leucine[1] Leucine 💬 --[1] 19 💬
24N-Acetyl-L-Leucine[1] Leucine[1] Leucine 💬 --[3] 18, 19, 65 💬
25N-Acetyl-L-LeucineProduct Code: IB1001Pharmaceutical Form: Powder and solvent for oral solutionINN or Proposed INN: N-Acetyl-L-leucineOther descriptive name: 2(S)-(ACETYLAMINO)-4-METHYLPENTANOIC ACIDConcentration unit: g gram(s)Concentration type: equalConcentration number: 1-Product Name: N-Acetyl-L-LeucineProduct Code: IB1001Pharmaceutical Form: Granules for oral suspension in sachetINN or Proposed INN: N-Acetyl-L-leucineOther descriptive name: 2(S)-(ACETYLAMINO)-4-METHYLPENTANOIC ACIDConcentration unit: g gram(s)Concentration type: equalConcentration number: 1-----[1] 65 💬
26N-acetylcystein----[1] 299 💬
27N-Acetylcysteine[1] Acetylcysteine[1] Acetylcysteine 💬 --[14] 6, 13, 19, 20, 21, 49, 58, 85, 90, 111, 164, 296, 299, 337 💬
28N-acetylcysteine (NAC)[1] Acetylcysteine[1] Acetylcysteine 💬 --[3] 34, 51, 299 💬
29N-Acetylcysteine (NAC) Treatment[1] Acetylcysteine[1] Acetylcysteine 💬 --[1] 6 💬
30N-Acetylcysteine Amide[2] Acetylcysteine,
Acetylcysteine amide
[1] Acetylcysteine 💬 --[3] 19, 90, 303 💬
31N-acetylcysteine capsule[1] Acetylcysteine[1] Acetylcysteine 💬 --[1] 6 💬
32N-acetylcysteine syrup[1] Acetylcysteine[1] Acetylcysteine 💬 --[1] 53 💬
33N-Acetylcysteine, (NAC)[1] Acetylcysteine[1] Acetylcysteine 💬 --[1] 85 💬
34N-acetylgalactosamine 4-sulfatase----[1] 19 💬
35N-Acetylglucosamine[1] N-Acetylglucosamine---[1] 96 💬
36N-Acetylglucosamine (GlcNAc)[1] N-Acetylglucosamine---[1] 96 💬
37N-acetylneuraminic acid----[1] 30 💬
38N-carbamylglutamate----[2] 245, 246 💬
39N-methyl D-(2,3,4,5,6-pentahydroxy-hexyl)-ammonium----[1] 28 💬
40N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine----[1] 13 💬
41N-{4-Chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamide, sodium----[1] 96 💬
42N-{4-Chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamidesodium----[1] 96 💬
43N. MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CONJUGATED TO----[1] 11 💬
44N. MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 ADSORBED ON ALUMINUM HYDROXIDE[2] Aluminum hydroxide,
Corynebacterium diphtheriae
[3] Aluminum hydroxide ,
Algeldrate ,
Almagate 💬
--[1] 11 💬
45N. MENINGITIDIS GROUP C POLYSACCHARIDE----[1] 14 💬
46N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197----[1] 13 💬
47N.a.----[11] 3, 6, 8, 13, 46, 63, 96, 97, 240, 256, 271 💬
48N/AProduct Code: RO7204239/F01-01Pharmaceutical Form: Solution for injectionINN or Proposed INN: N/ACAS Number: N/ACurrent Sponsor code: RO7204239Other descriptive name: GYM329Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 80-Pharmaceutical form of the placebo: Solution for injectionRoute of administration of the placebo: Subcutaneous use----[1] 3 💬
49N02BG10----[1] 13 💬
50N03AX12----[1] 13 💬
51N04BC07----[1] 6 💬
52N04BD02----[1] 6 💬
53N04BD03----[1] 6 💬
54N06DX01----[1] 13 💬
55N1,N3-BIS(2-MERCAPTOETHYL) ISOPHTHALAMIDE----[2] 5, 17 💬
56N6022----[1] 299 💬
57N91115----[1] 299 💬
58Na18F----[1] 13 💬
59Nab-sirolimus (also known as ABI-009, nab-rapamycin, albumin-bound rapamycin)[1] Sirolimus[1] Sirolimus 💬 [1] MTOR 💬 [52] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[1] 86 💬
60NABILONE[1] Nabilone[1] Nabilone 💬 [2] CNR1,
CNR2 💬
[4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬[4] 6, 13, 97, 127 💬
61Nabilone 0.25 mg[1] Nabilone[1] Nabilone 💬 [2] CNR1,
CNR2 💬
[4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬[1] 6 💬
62Nabiximols[1] Nabiximols[1] Nabiximols 💬 --[1] 13 💬
63Nabiximols - Sativex[1] Nabiximols[1] Nabiximols 💬 --[1] 13 💬
64NAC----[1] 8 💬
65NAC effervescent tablets----[1] 90 💬
66NaCl----[1] 227 💬
67NaCl 0,9%----[1] 53 💬
68NaCl 0.9%----[1] 39 💬
69Nacom----[1] 6 💬
70NACOM 100----[1] 6 💬
71NACOM levodopa+cardidopa[1] Levodopa[1] Levodopa 💬 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[13] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
72Nacystelyn[1] Nacystelyn---[1] 299 💬
73Nacystelyn®[1] Nacystelyn---[1] 299 💬
74NADH[1] NADH---[1] 302 💬
75Nadolol[1] Nadolol[1] Nadolol 💬 [2] ADRB1,
ADRB2 💬
[13] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
76Naglazyme----[1] 19 💬
77Naglazyme (galsulfase)[1] Galsulfase[1] Galsulfase 💬 [1] ARSB 💬 [2] Glycosaminoglycan degradation, Lysosome biogenesis 💬[1] 19 💬
78Naglazyme®----[1] 19 💬
79NAL----[2] 6, 299 💬
80NAL ER----[1] 85 💬
81Nalbuphine[1] Nalbuphine[2] Nalbuphine hydrochloride ,
Nalbuphine 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 85 💬
82Nalbuphine Extended-Realease (ER) Tablets[1] Nalbuphine[2] Nalbuphine hydrochloride ,
Nalbuphine 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 85 💬
83Nalbuphine Extended-Release (ER) Tablets[1] Nalbuphine[2] Nalbuphine hydrochloride ,
Nalbuphine 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 85 💬
84NALBUPHINE HYDROCHLORIDE[1] Nalbuphine[2] Nalbuphine hydrochloride ,
Nalbuphine 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 85 💬
85Naldemedine[1] Naldemedine[2] Naldemedine ,
Naldemedine tosylate 💬
[1] OPRM1 💬 [5] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 6 💬
86Nalmefene[1] Nalmefene[3] Nalmefene hydrochloride ,
Nalmefene ,
Nalmefene hydrochloride hydrate 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[2] 6, 93 💬
87Naloxone[1] Naloxone[3] Naloxone hydrochloride ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[2] 6, 226 💬
88NALOXONE HYDROCHLORIDE[1] Naloxone[3] Naloxone hydrochloride ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
89NALOXONE HYDROCHLORIDE DIHYDRATE[1] Naloxone[3] Naloxone hydrochloride ,
Naloxone ,
Naloxone hydrochloride dihydrate 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
90Naltrexone[1] Naltrexone[2] Naltrexone hydrochloride ,
Naltrexone 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[14] 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 49, 96, 97, 226 💬
91NALTREXONE CLORIDRATO[1] Naltrexone[2] Naltrexone hydrochloride ,
Naltrexone 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 10 💬
92NALTREXONE HYDROCHLORIDE[1] Naltrexone[2] Naltrexone hydrochloride ,
Naltrexone 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[9] 10, 40, 41, 42, 43, 44, 45, 96, 97 💬
93Naltrexone-HCl[1] Naltrexone[2] Naltrexone hydrochloride ,
Naltrexone 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 96 💬
94NAMILUMAB[1] Namilumab---[2] 46, 84 💬
95Namilumab (MT203)[1] Namilumab---[1] 46 💬
96NamilumabProduct Code: KIN-1902Pharmaceutical Form: Solution for injectionINN or Proposed INN: NAMILUMABCAS Number: 1206681-39-1Current Sponsor code: KIN-1902 (previously IZN-101, MT203, AMG203)Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 150-Pharmaceutical form of the placebo: Solution for injectionRoute of administration of the placebo: Subcutaneous use----[1] 84 💬
97Namisol----[2] 13, 298 💬
98Namuscla----[2] 114, 115 💬
99NAND (Neoandrographolide)----[1] 97 💬
100Nandrolone[1] Nandrolone[1] Nandrolone 💬 [1] AR 💬 [4] Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬[2] 60, 85 💬
101Nandrolone Decanoate[2] Nandrolone,
Nandrolone decanoate
[2] Nandrolone decanoate ,
Nandrolone 💬
[1] AR 💬 [4] Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬[2] 60, 85 💬
102Nanobody directed towards the human A1 domain of von Willebrand factor----[1] 64 💬
103Nanobubble drink----[1] 46 💬
104Nanocort----[3] 13, 46, 97 💬
105Nanocrystalline silver (Acticoat)[1] Silver---[2] 35, 162 💬
106Nanocurcumin----[2] 13, 271 💬
107Nanogam----[2] 57, 63 💬
108Nanogam 100 mg/ml----[1] 65 💬
109Nanogam® 50 mg/ml----[1] 65 💬
110Nanoparticulated Rebamipide[1] Rebamipide[1] Rebamipide 💬 --[1] 46 💬
111Nanosuspension)----[1] 113 💬
112Nap----[2] 96, 240 💬
113Napazimone----[1] 21 💬
114NaPBA----[1] 251 💬
115Naprosyn----[1] 271 💬
116Naprosyn 500 mg----[1] 46 💬
117Naprosysn----[1] 271 💬
118Naproxen[1] Naproxen[2] Naproxen ,
Naproxen sodium 💬
[2] PTGS1,
PTGS2 💬
[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[4] 13, 46, 107, 271 💬
119Naproxen (EC-Narosyn) Delayed Release Tables, 375 (Syntex (USA), Inc.)[1] Naproxen[2] Naproxen ,
Naproxen sodium 💬
[2] PTGS1,
PTGS2 💬
[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 46 💬
120Naproxen 10 mg/kg[1] Naproxen[2] Naproxen ,
Naproxen sodium 💬
[2] PTGS1,
PTGS2 💬
[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 46 💬
121Naproxen 500 mg tablets (PN 200 minus omeprazole)[2] Naproxen,
Omeprazole
[5] Naproxen ,
Omeprazole ,
Naproxen sodium ,
Omeprazole sodium ,
Omeprazole magnesium 💬
[4] ATP4A,
ATP4B,
PTGS1,
PTGS2 💬
[26] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Efferocytosis, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[2] 46, 271 💬
122Naproxen Delayed Release Tables, 375 (Gevena Pharmaceuticals, Inc.)[1] Naproxen[2] Naproxen ,
Naproxen sodium 💬
[2] PTGS1,
PTGS2 💬
[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 46 💬
123Naproxen oral suspension[1] Naproxen[2] Naproxen ,
Naproxen sodium 💬
[2] PTGS1,
PTGS2 💬
[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 46 💬
124NAPROXEN SODIUM[1] Naproxen[2] Naproxen ,
Naproxen sodium 💬
[2] PTGS1,
PTGS2 💬
[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 107 💬
125Naproxen sodium 550mg tablet[1] Naproxen[2] Naproxen ,
Naproxen sodium 💬
[2] PTGS1,
PTGS2 💬
[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 46 💬
126Nardil----[1] 6 💬
127Narsoplimab[1] Narsoplimab[1] Narsoplimab 💬 [1] MASP2 💬 [3] Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬[3] 66, 222, 223 💬
128Nasal Aztreonam[1] Aztreonam[2] Aztreonam ,
Aztreonam lysine 💬
--[1] 299 💬
129Nasal Methylprednisolone (MT)[1] Methylprednisolone[2] Methylprednisolone ,
Methylprednisolone acetate 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
130Nasal Nitric Oxide Measurement[1] Nitric Oxide[1] Nitric oxide 💬 --[1] 340 💬
131Nasal Nitric Oxide testing[1] Nitric Oxide[1] Nitric oxide 💬 --[1] 340 💬
132Nasal rinsing with saline 0.9%----[1] 299 💬
133Nasal rinsing with Xylitol[1] Xylitol[1] Xylitol 💬 --[1] 299 💬
134Nasojejunal (NJ) tube----[1] 6 💬
135Nasonex----[1] 98 💬
136Nasopharyngeal (Nasal) Samples----[1] 340 💬
137Nasopharyngeal swabs----[1] 46 💬
138NATALIZUMAB[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[5] 13, 15, 25, 46, 96 💬
139Natalizumab (BG00002)[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
140Natalizumab (NTZ)[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
141Natalizumab (Tysabri)[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
142Natalizumab 300 MG in 15 ML Injection[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
143Natalizumab for IV Infusion[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
144Natalizumab for Subcutaneous Injection[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
145Natalizumab Injection [Tysabri][1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
146Natalizumab IV[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
147Natalizumab SC[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
148Natalizumab treatment[1] Natalizumab[1] Natalizumab 💬 [1] ITGA4 💬 [17] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13 💬
149Natpar----[1] 235 💬
150Natpara----[1] 235 💬
151NATPARA/NATPAR----[1] 235 💬
152Natriumchlorid 0,9 %[1] Sodium chloride[1] Sodium chloride 💬 --[1] 288 💬
153Natriumklorid 9mg/ml----[1] 46 💬
154Natriuretic peptide----[1] 276 💬
155Natrunix----[1] 46 💬
156Natrunix 400 mg----[1] 46 💬
157Natural Matrix Protein (NMP) Fibers----[1] 70 💬
158NAV5001----[1] 6 💬
159Navenibart[1] Navenibart[1] Navenibart 💬 [1] KLKB1 💬 [1] Complement and coagulation cascades 💬[1] 65 💬
160Navepegritide[1] Navepegritide[1] Navepegritide 💬 [1] NPR2 💬 [5] Hormone signaling, Oxytocin signaling pathway, Purine metabolism, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 276 💬
161Navocaftor[1] Navocaftor[1] Navocaftor 💬 [1] CFTR 💬 [9] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299 💬
162NB-4746 (Dose TBD)----[1] 2 💬
163NB-4746 High dose----[1] 2 💬
164NB-4746 Low dose----[1] 2 💬
165NBI-5788----[1] 13 💬
166NBI-74788----[1] 81 💬
167NBI-77860----[1] 81 💬
168NBI-827104----[1] 154 💬
169NBMI----[2] 5, 17 💬
170NBT-NM108----[1] 193 💬
171NBT-NM108 (60 g/day)----[1] 13 💬
172NBTX-001----[1] 6 💬
173NC 1 cell therapy----[1] 117 💬
174NC-503 (Anti-amyloidotic (AA) Agent)----[2] 46, 222 💬
175NCA 500mg----[1] 93 💬
176Nd----[6] 2, 6, 13, 46, 51, 97 💬
177ND-L02-s0201 (High Dose)----[1] 85 💬
178ND-L02-s0201 (Low Dose)----[1] 85 💬
179ND-L02-s0201 for injection----[1] 85 💬
180ND0611----[1] 6 💬
181ND0612----[1] 6 💬
182ND0612 (Levodopa/Carbidopa solution)[2] Carbidopa,
Levodopa
[2] Levodopa ,
Carbidopa 💬
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6 💬
183ND0612 (Levodopa/Carbidopa solution) + morning oral IR-LD/CD[2] Carbidopa,
Levodopa
[2] Levodopa ,
Carbidopa 💬
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6 💬
184ND1421----[1] 6 💬
185ND1587----[1] 6 💬
186ND1589----[1] 6 💬
187ND1590----[1] 6 💬
188ND1702----[1] 6 💬
189NDI-5001[1] NDI-5001---[1] 225 💬
190NDV-3A----[1] 65 💬
191NDX-3315[1] NDX-3315---[1] 98 💬
192NDX-3324----[1] 98 💬
193NE3107----[1] 6 💬
194Near-infrared-induced autofluorescence and indocyanine green near-infrared angiography[2] Indocyanine green,
Indocyanine green acid form
[1] Indocyanine green 💬 --[1] 235 💬
195NEB/01-07----[1] 299 💬
196Nebcin----[1] 299 💬
197Nebcin (tobramycin)[1] Tobramycin[2] Tobramycin ,
Tobramycin sulfate 💬
--[1] 299 💬
198Nebcinal----[1] 299 💬
199Nebcinal Tobi----[1] 299 💬
200NEBCINE----[1] 299 💬
201Nebicapone[1] Nebicapone---[1] 6 💬
202NEBIDO----[1] 13 💬
203Nebido® Testosterone Undecanoate 1000 Mg/4 mL Solution for Injection[2] Testosterone,
Testosterone undecanoate
[2] Testosterone ,
Testosterone undecanoate 💬
[1] AR 💬 [4] Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬[1] 13 💬
204Nebivolol[1] Nebivolol[2] Nebivolol ,
Nebivolol hydrochloride 💬
[1] ADRB1 💬 [13] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[4] 17, 85, 113, 167 💬
205Nebivolol 5 mg[1] Nebivolol[2] Nebivolol ,
Nebivolol hydrochloride 💬
[1] ADRB1 💬 [13] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 17 💬
206Nebulization of Amikacin during NIV (RR: 15 cycles/minute)[1] Amikacin[2] Amikacin sulfate ,
Amikacin 💬
--[1] 299 💬
207Nebulization of Amikacin during NIV (RR: 25 cycles/minute)[1] Amikacin[2] Amikacin sulfate ,
Amikacin 💬
--[1] 299 💬
208Nebulization tobramycin[1] Tobramycin[2] Tobramycin ,
Tobramycin sulfate 💬
--[1] 299 💬
209Nebulized combination ipratropium bromide with salbutamol[1] Ipratropium---[1] 86 💬
210Nebulized Ensifentrine Suspension[1] Ensifentrine[1] Ensifentrine 💬 [6] PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D 💬
[11] Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 299 💬
211Nebulized ipratropium bromide[1] Ipratropium---[1] 86 💬
212Nebulized nitroglycerin[1] Nitroglycerin[1] Nitroglycerin 💬 --[1] 86 💬
213Nebulizer----[2] 6, 299 💬
214Necator americanus----[1] 13 💬
215Nedosiran[1] Nedosiran[1] Nedosiran sodium 💬 [1] LDHA 💬 [7] Central carbon metabolism in cancer, Cysteine and methionine metabolism, Glucagon signaling pathway, Glycolysis / Gluconeogenesis, HIF-1 signaling pathway, Propanoate metabolism, Pyruvate metabolism 💬[1] 234 💬
216Needle biopsy of the vastus lateralis muscle----[1] 113 💬
217NEFECON----[2] 66, 223 💬
218Nefecon 16mg daily----[1] 66 💬
219Nefecon®,Ambrisentan[1] Ambrisentan[1] Ambrisentan 💬 [1] EDNRA 💬 [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 66 💬
220Neflamapimod[1] Neflamapimod[1] Neflamapimod 💬 [4] MAPK11,
MAPK12,
MAPK13,
MAPK14 💬
[64] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Amyotrophic lateral sclerosis, C-type lectin receptor signaling pathway, Cadherin signaling, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Coronavirus disease, Diabetic cardiomyopathy, Dopaminergic synapse, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection 💬[1] 8 💬
221NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED WITH TETANUS TOXOID CARRIER PROTEIN----[1] 50 💬
222NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETA----[1] 50 💬
223NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN----[1] 50 💬
224Nelfinavir[1] Nelfinavir[2] Nelfinavir mesylate ,
Nelfinavir 💬
--[3] 49, 265, 331 💬
225Nelfinavir mesylate[1] Nelfinavir[2] Nelfinavir mesylate ,
Nelfinavir 💬
--[1] 265 💬
226Nelotanserin[1] Nelotanserin[1] Nelotanserin 💬 [1] HTR2A 💬 [6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬[1] 6 💬
227Nelutri™----[1] 84 💬
228Nemolizumab[1] Nemolizumab[1] Nemolizumab 💬 [1] IL31RA 💬 [2] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬[1] 51 💬
229Neo-ASA----[1] 251 💬
230NEO-GAA----[1] 256 💬
231Neo-Recormon----[1] 18 💬
232NEOD001----[1] 28 💬
233Neofordex----[1] 63 💬
234Neofordex 40 mg comprimés----[1] 63 💬
235Neofordex®----[1] 63 💬
236NeoFuse----[1] 70 💬
237NeoGAA[1] Avalglucosidase alfa[1] Avalglucosidase alfa 💬 [1] GAA 💬 [3] Galactose metabolism, Lysosome biogenesis, Starch and sucrose metabolism 💬[1] 256 💬
238NeoGAA or avalglucosidase alfa[1] Avalglucosidase alfa[1] Avalglucosidase alfa 💬 [1] GAA 💬 [3] Galactose metabolism, Lysosome biogenesis, Starch and sucrose metabolism 💬[1] 256 💬
239Neomycin[1] Neomycin[3] Neomycin sulfate ,
Neomycin palmitate ,
Neomycin 💬
--[3] 96, 97, 296 💬
240Neophyr 1000ppm mol/mol----[1] 294 💬
241Neoral----[3] 60, 97, 222 💬
242NEORAL 100 mg, capsule molle----[1] 60 💬
243Neoral Oral Solution----[1] 269 💬
244Neoral Soft Gelatin Capsules[1] Gelatin[1] Gelatin 💬 --[2] 97, 269 💬
245NeoRecormon[1] Epoetin beta[1] Epoetin beta 💬 [1] EPOR 💬 [7] Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[2] 13, 18 💬
246Neostigmine[1] Neostigmine[3] Neostigmine bromide ,
Neostigmine methylsulfate ,
Neostigmine 💬
[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[1] 11 💬
247Neovasculgen----[1] 51 💬
248Neovasculgen®----[1] 226 💬
249Neramexane[1] Neramexane---[1] 13 💬
250Neramexane mesylate[1] Neramexane---[1] 13 💬
251Nerandomilast[1] Nerandomilast[1] Nerandomilast 💬 [1] PDE4B 💬 [4] Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬[3] 2, 51, 85 💬
252Nerandomilast formulation 1[1] Nerandomilast[1] Nerandomilast 💬 [1] PDE4B 💬 [4] Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬[1] 51 💬
253Nerandomilast formulation 2[1] Nerandomilast[1] Nerandomilast 💬 [1] PDE4B 💬 [4] Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬[1] 51 💬
254Neratinib[1] Neratinib[2] Neratinib ,
Neratinib maleate 💬
[3] EGFR,
ERBB2,
ERBB4 💬
[51] Adherens junction, Amyotrophic lateral sclerosis, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease, Cushing syndrome, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction, Virion - Hepatitis viruses 💬[1] 34 💬
255Neridronic Acid[1] Neridronic Acid---[1] 6 💬
256Nerispirdine[1] Nerispirdine---[1] 13 💬
257Nerispirdine (HP184)[1] Nerispirdine---[1] 13 💬
258Nerispirdine hydrochloride[1] Nerispirdine---[1] 13 💬
259NERIXIA*IM EV 1F 25MG----[1] 6 💬
260NERIXIA*INFUS IV CONC 2F 100MG----[1] 274 💬
261Nerve block----[1] 46 💬
262Nerve Growt Factor - 2.5S----[1] 90 💬
263Nerve Growth Factor[1] Nerve Growth Factor---[5] 2, 3, 18, 53, 90 💬
264Nesiritide[1] Nesiritide[1] Nesiritide 💬 [1] NPR1 💬 [10] Aldosterone synthesis and secretion, Hormone signaling, Oxytocin signaling pathway, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 57 💬
265Nessuno----[1] 96 💬
266Nestle IMPACT Immunonutrition----[1] 97 💬
267NET/EE----[1] 67 💬
268Neu-120----[1] 6 💬
269NEU-411----[1] 6 💬
270NEUPOGEN----[4] 13, 28, 51, 285 💬
271NEUPRO----[2] 6, 127 💬
272Neupro (Reference)----[1] 6 💬
273NEUPRO - 2 MG/24 H + 4 MG/24 H + 6 MG/24 H+ 8 MG/24 H CEROTTO OTTO TRANSDERMICO 7 CEROTTI + 7 CEROTTI + 7 CEROTTI + 7 CEROTTI TRANDERMICI IN BUSTINA----[1] 127 💬
274NEUPRO 2 mg/24 h parche transdérmico----[1] 6 💬
275Neupro 2 mg/24 h transdermal patch----[1] 6 💬
276Neupro 2mg/24 h transdermal patch----[1] 6 💬
277Neupro 2mg/24h transdermal patch----[1] 6 💬
278NEUPRO 4 mg/24 h parche transdérmico----[1] 6 💬
279Neupro 4 mg/24 h transdermal patch----[1] 6 💬
280Neupro 4mg/24 h transdermal patch----[1] 6 💬
281Neupro 4mg/24h transdermal patch----[1] 6 💬
282Neupro 4Mg/24Hr Transdermal Patch----[1] 6 💬
283NEUPRO 6 mg/24 h parche transdérmico----[1] 6 💬
284Neupro 6 mg/24 h transdermal patch----[1] 6 💬
285Neupro 6mg/24 h transdermal patch----[1] 6 💬
286Neupro 6mg/24h transdermal patch----[1] 6 💬
287NEUPRO 8 mg/24 h parche transdérmico----[1] 6 💬
288Neupro 8 mg/24 h transdermal patch----[1] 6 💬
289Neupro 8mg/24h transdermal patch----[1] 6 💬
290Neupro ® 8 mg----[1] 6 💬
291NEUPRO*28CER 2MG/24H----[1] 6 💬
292NEUPRO*28CER 4MG/24H----[1] 6 💬
293NEUPRO*28CER 6MG/24H----[1] 6 💬
294NEUPRO*28CER 8MG/24H----[1] 6 💬
295NEUPRO*7CER 4MG/24H----[1] 6 💬
296NEUPRO*7CER 6MG/24H----[1] 6 💬
297NEUPRO*7CER 8MG/24H----[1] 6 💬
298Neupro®----[1] 6 💬
299Neupro® 8 mg/24 h----[1] 6 💬
300Neuraceq----[1] 6 💬
301Neuro-muscular biopsy and lumbar puncture----[1] 2 💬
302NEUROASPIS PLP10®----[1] 13 💬
303NEUROBLOC----[1] 6 💬
304NeuroCell-PD[1] NeuroCell-PD---[1] 6 💬
305NeuroEPO----[1] 6 💬
306Neurohormonal mechanisms----[1] 127 💬
307Neurological evaluation----[1] 25 💬
308Neuromodulation - Sacral nerve stimulation----[1] 26 💬
309Neuromuscular electrical stimulation delivered using the electrical therapy device EMPI 300 PV----[1] 13 💬
310NEURONTIN----[1] 13 💬
311Neurontin 300 mg hard capsule----[2] 13, 18 💬
312Neurostimulation----[1] 6 💬
313NEUROSWING Orthosis (experimental) : carbon orthosis with an active ankle articulation----[1] 13 💬
314NeuroVax[1] NeuroVax---[1] 13 💬
315NeuroVax 300ug/mL Dose for IM Injection[1] NeuroVax---[1] 13 💬
316Neurpro----[1] 6 💬
317Nevanimibe[1] Nevanimibe[2] Nevanimibe ,
Nevanimibe hydrochloride 💬
--[2] 75, 81 💬
318Nevanimibe hydrochloride[1] Nevanimibe[2] Nevanimibe ,
Nevanimibe hydrochloride 💬
--[2] 75, 81 💬
319Nevirapine[1] Nevirapine[1] Nevirapine 💬 --[1] 265 💬
320New formulation adalimumab[1] Adalimumab[1] Adalimumab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
321New Formulation Etanercept[1] Etanercept[1] Etanercept 💬 [2] LTA,
TNF 💬
[66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
322New Formulation of rebif - human interferon beta-1a[2] Human interferon beta,
Interferon beta-1a
[2] Interferon beta ,
Interferon beta-1a 💬
[2] IFNAR1,
IFNAR2 💬
[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
323New TETA 4HCl Formulation----[1] 171 💬
324New thermo stable formulation of epoprostenol sodium[1] Epoprostenol[2] Epoprostenol ,
Epoprostenol sodium 💬
[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
325NewGam----[3] 14, 63, 65 💬
326NewGam 10%----[1] 14 💬
327Newnorm----[1] 65 💬
328Nexavar----[1] 34 💬
329Nexavar (BAY 43-9006) (Sorafenib)[1] Sorafenib[2] Sorafenib tosylate ,
Sorafenib 💬
[8] BRAF,
FLT3,
FLT4,
KDR,
KIT,
PDGFRB,
RAF1,
RET 💬
[90] Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Cadherin signaling, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Influenza A, Insulin signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬[1] 34 💬
330Nexiguran ziclumeran----[1] 28 💬
331Nexium----[1] 299 💬
332Nexium (esomeprazole magnesium)[2] Esomeprazole,
Magnesium
[5] Esomeprazole magnesium ,
Esomeprazole sodium ,
Esomeprazole ,
Esomeprazole strontium ,
Esomeprazole magnesium dihydrate 💬
[2] ATP4A,
ATP4B 💬
[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[1] 298 💬
333Nexium 10 mg----[1] 234 💬
334Nexium 20----[1] 299 💬
335Next Generation Dome Helmet Focused Ultrasound----[1] 2 💬
336Nexviadyme----[1] 256 💬
337NFC-1----[1] 203 💬
338NFS-02[1] NFS-02---[1] 302 💬
339NFS-02 Injection[1] NFS-02---[1] 302 💬
340NFX-179 Gel----[1] 34 💬
341Ng-monomethyl-L-arginine (drug)[2] Arginine,
L-arginine
[3] Arginine hydrochloride ,
Arginine ,
Arginine hydrochloride 💬
--[2] 67, 223 💬
342NG01 - Autologous bone marrow derived human stromal cells----[1] 13 💬
343NGGT002----[1] 240 💬
344NGGT006----[1] 79 💬
345NGM/EE----[1] 67 💬
346NGM282----[2] 93, 94 💬
347NGN-101[1] NGN-101---[1] 19 💬
348NGN-401[1] NGN-401---[1] 156 💬
349NGS----[2] 61, 63 💬
350NGX267[1] NGX267---[1] 53 💬
351NHS7108----[1] 299 💬
352NI-0101----[1] 46 💬
353NI-03----[1] 298 💬
354NI-0401 (anti-CD3 mAB)----[1] 96 💬
355NI-0501----[3] 49, 54, 107 💬
356NI-071----[1] 46 💬
357NI-0801----[1] 93 💬
358Niacin[1] Niacin[1] Niacin 💬 --[4] 6, 46, 79, 265 💬
359Niacin sustained release capsules[1] Niacin[1] Niacin 💬 --[1] 46 💬
360Niacinamide----[3] 6, 13, 67 💬
361Nicardipine[1] Nicardipine[2] Nicardipine hydrochloride ,
Nicardipine 💬
[4] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬
[37] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[2] 70, 86 💬
362Niclosamide[1] Niclosamide[1] Niclosamide 💬 --[2] 46, 97 💬
363Nicolon----[1] 97 💬
364Nicorandil[1] Nicorandil[1] Nicorandil 💬 [6] ABCC8,
ABCC9,
GUCY1A1,
GUCY1A2,
GUCY1B1,
KCNJ11 💬
[14] ABC transporters, Circadian entrainment, Gap junction, GnRH secretion, Insulin secretion, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 46 💬
365Nicorandil 5 MG Oral Tablet[1] Nicorandil[1] Nicorandil 💬 [6] ABCC8,
ABCC9,
GUCY1A1,
GUCY1A2,
GUCY1B1,
KCNJ11 💬
[14] ABC transporters, Circadian entrainment, Gap junction, GnRH secretion, Insulin secretion, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 46 💬
366Nicorette 10mg/ 16 h----[1] 6 💬
367Nicorette 15 mg/ 16 h----[1] 6 💬
368Nicorette 5 mg/ 16 h----[1] 6 💬
369Nicotinamid riboside----[1] 13 💬
370Nicotinamide[1] Nicotinamide[1] Niacinamide 💬 --[19] 2, 5, 6, 7, 8, 17, 18, 21, 46, 49, 60, 63, 65, 85, 97, 107, 162, 191, 302 💬
371Nicotinamide adenine dinucleotid/nicotinamide mononucleotide[3] Adenine,
Nicotinamide,
Nicotinamide Mononucleotide
[2] Adenine ,
Niacinamide 💬
--[1] 63 💬
372Nicotinamide Mononucleotide[2] Nicotinamide,
Nicotinamide Mononucleotide
[1] Niacinamide 💬 --[2] 63, 97 💬
373Nicotinamide riboside[2] Nicotinamide,
Nicotinamide riboside
[1] Niacinamide 💬 --[14] 2, 5, 6, 7, 8, 17, 18, 21, 49, 60, 65, 85, 97, 191 💬
374Nicotinamide Riboside (NR)[2] Nicotinamide,
Nicotinamide riboside
[1] Niacinamide 💬 --[1] 8 💬
375Nicotinamide Riboside Chloride[2] Nicotinamide,
Nicotinamide riboside
[1] Niacinamide 💬 --[1] 97 💬
376Nicotinamide Tablet[1] Nicotinamide[1] Niacinamide 💬 --[1] 46 💬
377Nicotinamide treatment[1] Nicotinamide[1] Niacinamide 💬 --[2] 21, 302 💬
378NICOTINE[1] Nicotine[3] Nicotine ,
Nicotine bitartrate ,
Nicotine polacrilex 💬
[16] CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬
[9] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬[3] 6, 13, 84 💬
379Nicotine gum[1] Nicotine[3] Nicotine ,
Nicotine bitartrate ,
Nicotine polacrilex 💬
[16] CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬
[9] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬[1] 6 💬
380Nicotine Nasal Spray 10 MG/ML (0.5 MG/SPRAY)[1] Nicotine[3] Nicotine ,
Nicotine bitartrate ,
Nicotine polacrilex 💬
[16] CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬
[9] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬[1] 6 💬
381Nicotine patch[1] Nicotine[3] Nicotine ,
Nicotine bitartrate ,
Nicotine polacrilex 💬
[16] CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬
[9] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬[2] 6, 84 💬
382Nicotine transdermal patch[1] Nicotine[3] Nicotine ,
Nicotine bitartrate ,
Nicotine polacrilex 💬
[16] CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬
[9] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬[1] 6 💬
383Nicotinell----[1] 6 💬
384Nicotinell 17,5 mg/24-Stunden-Pflaster----[1] 6 💬
385Nicotinell 35 mg/24-Stunden-Pflaster----[1] 6 💬
386Nicotinic acid----[1] 79 💬
387Nicotinic acid/laropiprant[2] Laropiprant,
Niacin
[2] Niacin ,
Laropiprant 💬
[1] PTGDR 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 79 💬
388NIDO-361----[1] 1 💬
389Nifedipine[1] Nifedipine[1] Nifedipine 💬 [4] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬
[37] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[2] 50, 81 💬
390Nifuroxazide[1] Nifuroxazide[1] Nifuroxazide 💬 --[1] 97 💬
391Nilemdo----[1] 79 💬
392Nilemdo Product Name: bempedoic acidPharmaceutical Form: TabletINN or Proposed INN: Bempedoic acidCAS Number: 738606-46-7 Current Sponsor code: ETC-1002----[1] 79 💬
393Nilotinib[1] Nilotinib[1] Nilotinib 💬 [4] ABL1,
KIT,
PDGFRA,
PDGFRB 💬
[35] Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[5] 6, 8, 34, 51, 86 💬
394Nilotinib (Tasigna)[1] Nilotinib[1] Nilotinib 💬 [4] ABL1,
KIT,
PDGFRA,
PDGFRB 💬
[35] Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[1] 51 💬
395Nilotinib 150 MG[1] Nilotinib[1] Nilotinib 💬 [4] ABL1,
KIT,
PDGFRA,
PDGFRB 💬
[35] Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[1] 8 💬
396Nilotinib 150mg oral capsule [Tasigna][1] Nilotinib[1] Nilotinib 💬 [4] ABL1,
KIT,
PDGFRA,
PDGFRB 💬
[35] Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[1] 6 💬
397Nilotinib 300mg oral capsule [Tasigna][1] Nilotinib[1] Nilotinib 💬 [4] ABL1,
KIT,
PDGFRA,
PDGFRB 💬
[35] Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[1] 6 💬
398Nilotinib 50 mg[1] Nilotinib[1] Nilotinib 💬 [4] ABL1,
KIT,
PDGFRA,
PDGFRB 💬
[35] Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[1] 86 💬
399NILOTINIB HYDROCHLORIDE MONOHYDRATE[1] Nilotinib[1] Nilotinib 💬 [4] ABL1,
KIT,
PDGFRA,
PDGFRB 💬
[35] Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[1] 34 💬
400Nilvadipine[1] Nilvadipine[1] Nilvadipine 💬 [4] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬
[37] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 90 💬
401Nimenrix----[4] 50, 61, 63, 223 💬
402Nimesulide[1] Nimesulide[1] Nimesulide 💬 [1] PTGS2 💬 [22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 46 💬
403Ninerafaxstat[1] Ninerafaxstat[1] Ninerafaxstat 💬 --[1] 58 💬
404Ninerafaxstat 200mg MR[1] Ninerafaxstat[1] Ninerafaxstat 💬 --[1] 58 💬
405Ninlaro----[2] 61, 63 💬
406NINTEDANIB[1] Nintedanib[2] Nintedanib esylate ,
Nintedanib 💬
[8] FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬
[36] Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬[7] 51, 84, 85, 89, 227, 228, 331 💬
407Nintedanib 150 mg and 100 mg soft capsules[1] Nintedanib[2] Nintedanib esylate ,
Nintedanib 💬
[8] FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬
[36] Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬[1] 227 💬
408Nintedanib,Dextromethorphan[2] Dextromethorphan,
Nintedanib
[5] Dextromethorphan hydrobromide ,
Dextromethorphan ,
Dextromethorphan polistirex ,
Nintedanib esylate ,
Nintedanib 💬
[14] FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
KDR,
PDGFRA,
PDGFRB,
SIGMAR1 💬
[54] Adherens junction, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, Glutamatergic synapse, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Huntington disease, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, Long-term potentiation, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prion disease, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Spinocerebellar ataxia, Systemic lupus erythematosus, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway, cAMP signaling pathway 💬[1] 85 💬
409Nintendo Wii Fit Balance Board----[1] 13 💬
410Nintédanib----[1] 227 💬
411NIOX MINO® Airway Inflammation Monitor----[1] 98 💬
412NIP292----[1] 85 💬
413NIP292 tablet----[1] 85 💬
414NIP292 tablets----[1] 85 💬
415Nipocalimab[1] Nipocalimab[1] Nipocalimab 💬 --[6] 11, 14, 46, 49, 53, 61 💬
416Nipocalimab Product Code: JNJ-80202135Pharmaceutical Form: Solution for infusionINN or Proposed INN: NipocalimabCAS Number: 2211985-36-1Current Sponsor code: JNJ-80202135Other descriptive name: M281Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 30-Pharmaceutical form of the placebo: Solution for infusionRoute of administration of the placebo: Intravenous use[1] Nipocalimab[1] Nipocalimab 💬 --[1] 11 💬
417Nipocalimab SC-LIV[1] Nipocalimab[1] Nipocalimab 💬 --[1] 11 💬
418NIRS----[1] 97 💬
419NIRS after bosentan administration[1] Bosentan[2] Bosentan ,
Bosentan 💬
[2] EDNRA,
EDNRB 💬
[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
420NIRS baseline----[1] 13 💬
421Nitazoxanide[1] Nitazoxanide[1] Nitazoxanide 💬 --[3] 46, 96, 97 💬
422Nitazoxanide 500Mg Oral Tablet[1] Nitazoxanide[1] Nitazoxanide 💬 --[2] 46, 97 💬
423NITISINONE[1] Nitisinone[1] Nitisinone 💬 [1] HPD 💬 [3] Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬[3] 6, 164, 241 💬
424Nitisinone 10 mg Tablet High Compritol[1] Nitisinone[1] Nitisinone 💬 [1] HPD 💬 [3] Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬[1] 241 💬
425Nitisinone Baked Tablet[1] Nitisinone[1] Nitisinone 💬 [1] HPD 💬 [3] Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬[1] 241 💬
426Nitrate[1] Nitrate[1] Nitric acid 💬 --[6] 57, 58, 67, 85, 113, 299 💬
427Nitrate-depleted beetroot juice[1] Nitrate[1] Nitric acid 💬 --[1] 67 💬
428Nitrate-rich beetroot juice (70ml with approx. 400 mg nitrate) twice a day for 3 days[1] Nitrate[1] Nitric acid 💬 --[1] 85 💬
429Nitrazepam[1] Nitrazepam[1] Nitrazepam 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬
[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 145 💬
430Nitric Oxide[1] Nitric Oxide[1] Nitric oxide 💬 --[12] 46, 51, 85, 86, 88, 97, 98, 210, 251, 294, 299, 340 💬
431Nitric Oxide 160 ppm[1] Nitric Oxide[1] Nitric oxide 💬 --[1] 299 💬
432Nitric Oxide for inhalation[1] Nitric Oxide[1] Nitric oxide 💬 --[2] 86, 299 💬
433Nitric Oxide generated by the GeNO nitrosyl delivery system[1] Nitric Oxide[1] Nitric oxide 💬 --[1] 86 💬
434Nitric Oxide plus Oxygen[2] Nitric Oxide,
Oxygen
[2] Oxygen ,
Nitric oxide 💬
--[1] 86 💬
435Nitric oxide supplement[1] Nitric Oxide[1] Nitric oxide 💬 --[1] 251 💬
436Nitrite[1] Nitrite---[3] 58, 86, 299 💬
437Nitrofurantoin[1] Nitrofurantoin[1] Nitrofurantoin 💬 --[1] 13 💬
438Nitrogen[1] Nitrogen[1] Nitrogen 💬 --[6] 5, 6, 17, 171, 211, 299 💬
439Nitroglycerin[1] Nitroglycerin[1] Nitroglycerin 💬 --[2] 51, 86 💬
440Nitroglycerin Ointment 2%[1] Nitroglycerin[1] Nitroglycerin 💬 --[1] 51 💬
441Nitroglycerine gel----[1] 51 💬
442Nitroprusside[1] Nitroprusside[1] Sodium nitroprusside 💬 --[1] 51 💬
443Nitrous Oxide[1] Nitrous oxide[1] Nitrous oxide 💬 --[1] 34 💬
444NiuBangZi pill----[1] 46 💬
445Nivolumab[1] Nivolumab[1] Nivolumab 💬 [1] PDCD1 💬 [3] Cell adhesion molecule (CAM) interaction, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬[12] 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
446NIZORAL----[1] 75 💬
447Nizubaglustat[1] Nizubaglustat[1] Nizubaglustat 💬 [2] GBA2,
UGCG 💬
[3] Cornified envelope formation, Other glycan degradation, Sphingolipid metabolism 💬[1] 19 💬
448NJ-Tube: Silicon ED Tube[1] Silicon---[1] 6 💬
449NK 010 or NK042----[1] 49 💬
450NK 104----[1] 79 💬
451NK cells----[1] 26 💬
452NK042----[1] 13 💬
453NK510 : allogeneic genetic modified NK----[1] 49 💬
454NKX019----[4] 46, 49, 51, 222 💬
455NL-ATN1-001----[1] 18 💬
456NL-ATN1-002----[1] 18 💬
457NL-CHCHD-001----[1] 2 💬
458NL-FLVC-001----[1] 90 💬
459NL-GARS1-001----[1] 10 💬
460NL-TARD-001----[1] 2 💬
461NL003----[1] 47 💬
462Nle4-D-Phe7-alpha-MSH----[1] 254 💬
463NLX-112----[1] 6 💬
464NLY01----[2] 6, 13 💬
465NM8074----[5] 50, 62, 66, 109, 223 💬
466NMD670----[3] 3, 10, 11 💬
467NNC 0109-0000-0012----[1] 46 💬
468NNC 0141-0000-0100----[1] 46 💬
469NNC 0142-0000-0002----[2] 46, 96 💬
470NNC 0151-0000-0000----[2] 46, 49 💬
471NNC 142-0002----[1] 46 💬
472NNC0109-0012----[1] 46 💬
473NNC0114-0000-0005----[1] 46 💬
474NNC0114-0006[1] NNC0114-0006---[3] 46, 49, 96 💬
475NNC0142-0000-0002----[1] 96 💬
476NNC0142-0002----[1] 46 💬
477NNC0151-0000-0000----[1] 46 💬
478NNC0215-0384----[2] 46, 162 💬
479NNC109-0012----[1] 46 💬
480NNC142-0002----[1] 96 💬
481NNC151-0000----[1] 46 💬
482NNC6019-0001----[1] 28 💬
483NNC6019-0001 A 250 mg----[1] 28 💬
484NNZ-2566----[2] 156, 206 💬
485NNZ-2591[1] NNZ-2591---[2] 193, 201 💬
486No----[3] 46, 62, 299 💬
487NO4BD03----[1] 6 💬
488Nocturnal oxygen , nocturnal bi-level positive pressure ventilation[1] Oxygen[1] Oxygen 💬 --[1] 299 💬
489NOE-101----[1] 158 💬
490Nolpitantium Besylate----[1] 97 💬
491NOMACOPAN[1] Nomacopan[1] Nomacopan 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 162 💬
492Nomacopan (rVA576)[1] Nomacopan[1] Nomacopan 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 162 💬
493Nomegestrol[1] Nomegestrol[1] Nomegestrol 💬 [1] PGR 💬 [5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 13 💬
494Nomegestrol acetate[3] Acetate,
Nomegestrol,
Nomegestrol acetate
[2] Nomegestrol ,
Nomegestrol acetate 💬
[1] PGR 💬 [5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 13 💬
495Nomlabofusp[1] Nomlabofusp---[1] 18 💬
496NON APPLICABILE----[3] 49, 51, 256 💬
497Non applicable----[2] 10, 19 💬
498Non as of yet----[1] 97 💬
499Non ATG Conditioning regimen----[1] 60 💬
500NON COMMERCIAL----[1] 75 💬
501Non disponibile----[2] 13, 201 💬
502Non intervention-Monitoring device----[1] 6 💬
503Non invasive ventilation----[1] 299 💬
504NON PROPIETRY, THEREFORE N/A----[1] 51 💬
505Non-active stimulation----[1] 46 💬
506Non-anti-TNF biologics----[2] 46, 271 💬
507Non-biologic anti-rheumatic drugs----[1] 46 💬
508Non-biologic Disease Modifying Anti-Rheumatic Drug (DMARD)----[1] 46 💬
509Non-Biologic DMARDs----[3] 46, 86, 107 💬
510Non-biological DMARDs----[1] 46 💬
511Non-enteric coated pancreatic enzyme preparation----[1] 298 💬
512Non-Interventional Study----[1] 97 💬
513Non-invasive ultrasound stimulation of the spleen - Treatment Setting 1----[1] 46 💬
514Non-invasive ultrasound stimulation of the spleen - Treatment Setting 2----[1] 46 💬
515Non-mavacamten symptomatic oHCM therapy[1] Mavacamten[1] Mavacamten 💬 [1] MYH7 💬 [9] Adrenergic signaling in cardiomyocytes, Cardiac muscle contraction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Motor proteins, Thyroid hormone signaling pathway, Viral myocarditis, cGMP-PKG signaling pathway 💬[1] 58 💬
516Non-myeloablative Hematopoietic Stem Cell Transplantation----[1] 93 💬
517Non-myeloablative high dose immunosuppressive therapy conditioning (HDIT)----[1] 49 💬
518Non-nucleoside reverse transcriptase inhibitors----[1] 265 💬
519Non-pegylated interferon----[1] 13 💬
520Non-steroidal anti-inflammatory drug----[1] 46 💬
521Non-steroidal anti-inflammatory drug (NSAID)----[1] 46 💬
522Non-steroidal anti-inflammatory drugs----[1] 46 💬
523Non-steroidal anti-inflammatory drugs (NSAIDs)----[1] 107 💬
524Non-steroidal mineralocorticoid receptor antagonist and SoC----[2] 66, 223 💬
525Non-TNFi-biologic class----[1] 46 💬
526Nonbiologic DMARDs of investigator's choice----[1] 46 💬
527None----[14] 13, 46, 65, 84, 85, 96, 97, 106, 160, 161, 171, 222, 223, 299 💬
528None as of yet----[1] 46 💬
529None assigned----[2] 231, 299 💬
530None at this time----[2] 96, 140 💬
531None given----[1] 97 💬
532None yet----[3] 51, 85, 222 💬
533Nonmyeloablative allogeneic hematopoietic stem cell transplantation----[6] 28, 51, 60, 62, 65, 285 💬
534Norantipyrine----[1] 2 💬
535Nordiet----[1] 97 💬
536Nordimet 7,5 mg solution injectable en stylo prérempli----[1] 46 💬
537Norditropin----[1] 195 💬
538Norditropin 24 IU----[1] 195 💬
539Norditropin FlexPro 10 mg/1.5 ml, solution for injection in pre-filled pen----[1] 195 💬
540Norditropin SimpleXx----[5] 3, 97, 107, 193, 195 💬
541Norditropin SimpleXx 15 mg/1.5 ml----[1] 3 💬
542Norditropin SimpleXx 5mg/1.5ml----[1] 107 💬
543Norditropine simplex----[1] 238 💬
544Norditropin®----[1] 195 💬
545Norditropin® SimpleXx® 5mg/1.5ml----[1] 97 💬
546Norepinephrine[1] Norepinephrine[3] Noradrenaline ,
Norepinephrine bitartrate ,
Norepinephrine hydrochoride 💬
[9] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
[16] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[2] 22, 296 💬
547Norepinephrine Bitartrate[1] Norepinephrine[3] Noradrenaline ,
Norepinephrine bitartrate ,
Norepinephrine hydrochoride 💬
[9] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
[16] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 296 💬
548Norethindrone----[2] 13, 49 💬
549Norethindrone Acetate-Ethinyl Estradiol[2] Acetate,
Estradiol
[2] Estradiol ,
Estradiol hemihydrate 💬
[2] ESR1,
ESR2 💬
[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 78 💬
550Norgestimate[1] Norgestimate[1] Norgestimate 💬 [1] PGR 💬 [5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[2] 118, 299 💬
551Norgestimate-ethinyl estradiol, with or without folic acid[3] Estradiol,
Folic acid,
Norgestimate
[5] Folic acid ,
Estradiol ,
Norgestimate ,
Estradiol hemihydrate ,
Folate sodium 💬
[3] ESR1,
ESR2,
PGR 💬
[12] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 118 💬
552Normal dietetic scheme----[1] 97 💬
553Normal human immunoglobulin G[1] Human immunoglobulin G[1] Globulin, immune 💬 --[1] 65 💬
554Normal oral intake of the traditional formula----[1] 296 💬
555Normal Saline----[20] 6, 13, 17, 22, 36, 46, 49, 60, 70, 71, 79, 94, 96, 97, 210, 211, 226, 276, 296, 299 💬
556Normal Saline (0.9% NaCl)----[1] 97 💬
557Normal Saline 0.9% Infusion Solution----[1] 22 💬
558Normal Saline Enema----[1] 97 💬
559Normal Saline for Injection----[1] 13 💬
560Normal saline instillation----[1] 226 💬
561Normal Saline IV Administration----[1] 65 💬
562Normal saline IV, salt tablets----[1] 299 💬
563Normal saline solution----[1] 299 💬
564Normal saline:----[1] 299 💬
565NORMIX*AD 12CPR RIV 200MG----[1] 96 💬
566Normotensive patients----[1] 70 💬
567Norovirus -specific T-cell (NST) therapy----[1] 65 💬
568Norphenazone[1] Edaravone[1] Edaravone 💬 --[1] 2 💬
569NORPROLAC----[1] 74 💬
570Northera----[1] 6 💬
571Nortriptyline[1] Nortriptyline[2] Nortriptyline hydrochloride ,
Nortriptyline 💬
[2] SLC6A2,
SLC6A4 💬
[3] Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬[2] 6, 226 💬
572Nortriptyline hydrochloride[1] Nortriptyline[2] Nortriptyline hydrochloride ,
Nortriptyline 💬
[2] SLC6A2,
SLC6A4 💬
[3] Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 6 💬
573Norucholic acid[1] norUrsodeoxycholic acid[1] Norucholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[2] 93, 94 💬
574Norucholic acid (NCA) 500 mg----[1] 93 💬
575Norucholic acid (NCA) 500 mgProduct Code: NCA 500mgPharmaceutical Form: Film-coated tabletINN or Proposed INN: Norucholic acidCAS Number: 9697-24-2Current Sponsor code: NCAOther descriptive name: norucholic acidConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 500-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral use----[1] 93 💬
576NorUDCA----[1] 94 💬
577NorUDCA (Norursodeoxycholic acid)[1] norUrsodeoxycholic acid[1] Norucholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 94 💬
578NorUrsodeoxycholic Acid[1] norUrsodeoxycholic acid[1] Norucholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 94 💬
579Norursodeoxycholic acid, NCA[1] norUrsodeoxycholic acid[1] Norucholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 94 💬
580Norvir----[2] 265, 299 💬
581Norvir 100 mg film-coated tablets----[1] 299 💬
582NouvNeu001 injection----[1] 6 💬
583NOVANTRONE*INF 2MG/ML 5ML----[1] 13 💬
584Novartis Pharmaceuticals Corporation----[1] 13 💬
585NOVATREX----[1] 13 💬
586Novo Rapid----[1] 299 💬
587Novo Rapid Insulin (Novonordisk)----[1] 299 💬
588Novolin-R insulin----[1] 127 💬
589NovoNorm 0.5 mg----[1] 299 💬
590NovoNorm 1 mg----[1] 299 💬
591NovoNorm 2 mg----[1] 299 💬
592Novorapid / humalog short acting insulin----[1] 299 💬
593NovoRapid 100 U/ml, solution for injection in a vial. NovoRapid Penfill 100 U/ml, solution for injection in a cartridge. NovoRapid FlexPen 100 U/ml, solution for injection in a pre-filled pen.----[1] 299 💬
594NovoRapid Aspartate----[1] 299 💬
595Now Foods L-Ornithine Capsules[1] Ornithine[2] Ornithine ,
Ornithine aspartate 💬
--[1] 96 💬
596NOX-E36----[1] 49 💬
597Noxafil----[2] 65, 299 💬
598NOXAFIL - 40 mg/ml oral suspension----[1] 299 💬
599NOXAFIL - 40 MG/ML SOSPENSIONE ORALE USO ORALE FLACONE (VETRO) 105 ML 1 FLACONE----[1] 299 💬
600NOXAFIL - oral suspension 40 mg/ml----[1] 299 💬
601Noxafil 100 mg----[1] 299 💬
602Noxafil 100 mg Tablets Gastro-Resistant----[1] 299 💬
603Noxafil 40 mg/ml oral solution----[1] 65 💬
604Noxafil Gastro resistant tablets----[1] 60 💬
605Noxafil®----[2] 60, 299 💬
606NP-201 acetate injection (Part A)[1] Acetate---[1] 97 💬
607NP001----[1] 2 💬
608NP031112----[1] 5 💬
609NP031112 600mg----[1] 5 💬
610NP031112 800mg----[1] 5 💬
611NPB-01----[3] 13, 14, 162 💬
612NPC transplantation----[1] 6 💬
613NPC-02----[1] 171 💬
614NPC-09----[1] 30 💬
615NPC-12G gel----[2] 34, 158 💬
616NPC-12Y gel----[1] 158 💬
617NPC-14----[1] 113 💬
618NPI-001----[2] 90, 303 💬
619NPL-2009----[1] 206 💬
620Nplate----[2] 60, 63 💬
621NPLATE 500 microgramos polvo para solución inyectable----[1] 63 💬
622NPSP 558----[1] 235 💬
623NPSP558----[1] 235 💬
624NR----[1] 299 💬
625NR082 Injection----[1] 302 💬
626NR2B NMDA Antagonist CP-101,606 (traxoprodil)[1] Traxoprodil---[1] 6 💬
627NS----[1] 2 💬
628NS 2330----[1] 6 💬
629NS-050/NCNP-03----[1] 113 💬
630NS-065/NCNP-01----[1] 113 💬
631NS-089/NCNP-02----[1] 113 💬
632NS-229----[2] 44, 45 💬
633NS-304----[1] 86 💬
634NS-863 High Dose----[1] 86 💬
635NS-863 Low Dose----[1] 86 💬
636NS101 IV infusion----[1] 127 💬
637NS2330----[1] 6 💬
638NSAID----[2] 270, 271 💬
639NSAIDs----[4] 46, 70, 107, 271 💬
640NSAIDs (permitted,not necessary)----[1] 46 💬
641NSAIDs and sulfasalazine[1] Sulfasalazine[1] Sulfasalazine 💬 --[1] 271 💬
642NsNSAIDs----[2] 107, 271 💬
643NSP001----[1] 96 💬
644NT 101----[4] 5, 6, 7, 17 💬
645NT-501----[2] 90, 303 💬
646NT-I7----[1] 25 💬
647NT-KO-003----[1] 13 💬
648NTBC----[1] 241 💬
649NTCELL Implantation----[1] 6 💬
650NTI164----[1] 156 💬
651NTLA-2001[1] NTLA-2001---[1] 28 💬
652NTLA-2002[1] NTLA-2002---[1] 65 💬
653NTQ5082 100mg qd----[1] 62 💬
654NTQ5082 200mg qd----[1] 62 💬
655NTQ5082 capsules 100 mg----[1] 66 💬
656NTQ5082 capsules 200 mg----[2] 62, 66 💬
657NTQ5082 capsules 300 mg----[1] 66 💬
658NTR1011----[2] 46, 49 💬
659NU100----[1] 13 💬
660NUCALA----[2] 44, 45 💬
661Nucala 100 mg powder for solution for injection----[2] 44, 45 💬
662NUCALA®----[1] 44 💬
663NuCel----[1] 70 💬
664NucleomaxX----[1] 265 💬
665Nucleoside analogue sparing HAART regimen----[1] 265 💬
666Nucleoside reverse transcriptase inhibitors----[1] 265 💬
667Nucresiran----[1] 28 💬
668Nuedexta----[1] 2 💬
669Nulojix----[1] 46 💬
670NUPLAZID----[1] 6 💬
671NUPLAZID 34 MG Oral Capsule----[1] 6 💬
672NurOwn (MSC-NTF cells)----[2] 2, 13 💬
673NurOwn® (MSC-NTF cells)----[1] 2 💬
674Nursinersen----[1] 3 💬
675NUSINERSEN[1] Nusinersen[2] Nusinersen sodium ,
Nusinersen 💬
--[1] 3 💬
676Nusinersen Injectable Product[1] Nusinersen[2] Nusinersen sodium ,
Nusinersen 💬
--[1] 3 💬
677NUSINERSEN SODIUM[1] Nusinersen[2] Nusinersen sodium ,
Nusinersen 💬
--[1] 3 💬
678Nusinersen Treatments[1] Nusinersen[2] Nusinersen sodium ,
Nusinersen 💬
--[1] 3 💬
679Nutraceutical Combination----[1] 96 💬
680Nutridrink-Impact----[1] 299 💬
681Nutrition supplement----[1] 97 💬
682Nutrition treat----[1] 96 💬
683Nutritional dietary intervention----[2] 96, 97 💬
684Nutritional Formulation Containing Exogenous Ketones----[1] 201 💬
685Nutritional Ketone Supplement----[2] 317, 344 💬
686Nutritional Supplement----[1] 90 💬
687Nutropin AQ----[4] 78, 134, 193, 299 💬
688Nutropin AQ [somatropin (DNA origin) injection]----[1] 299 💬
689NutropinAq 10mg/2ml (30 I.E.) Injektionsllösung----[1] 65 💬
690NutropinAq 10mg/2ml solution for injection----[1] 96 💬
691NutropinAq®----[1] 96 💬
692Nuvion®)----[1] 97 💬
693NUZ-001----[1] 2 💬
694NV1205----[1] 20 💬
695NVF233----[1] 13 💬
696NVG-2089----[2] 14, 63 💬
697NW-1015----[1] 6 💬
698NW-1015E, EMD 1195686, MSC2191632B----[1] 6 💬
699NX-13 250 mg----[1] 97 💬
700NX-13 250mg----[1] 97 💬
701NX-13 250mg IR----[1] 97 💬
702NX-13 500mg IR----[1] 97 💬
703NX-13 500mg MR----[1] 97 💬
704NX-13 750mg----[1] 97 💬
705NX1011----[1] 86 💬
706NX210c----[1] 2 💬
707NXC-201 CAR-T----[1] 28 💬
708NYX-458----[1] 6 💬
709Nébivolol----[1] 113 💬